Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 
R. Daniel  Beauchamp

R. Daniel Beauchamp, M.D., F.A.C.S.

John Clinton Foshee Distinguished Professor of Surgery (Surgical Oncology)
Chairman, Section of Surgical Sciences
Surgeon-in-Chief, Vanderbilt University Hospital
Deputy Director, Vanderbilt-Ingram Cancer Center
Surgical Oncologist

  • Appointments
    615-322-2064
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Vanderbilt Breast Center One Hundred Oaks
    615-322-2064; Referring Physicians: 615-343-9283

    Vanderbilt University Medical Center
    615-322-5000

    Office
    615-322-2363
  • Faxes
    Vanderbilt Breast Center One Hundred Oaks Fax
    615-343-7622
  • Addresses
    Vanderbilt Breast Center One Hundred Oaks
    719 Thompson Lane, Suite 25000
    Nashville, TN 37204
    Website

    Vanderbilt University Medical Center
    1211 Medical Center Drive
    Nashville, TN 37232
    Website

    Office
    Vanderbilt University Medical Center
    D-4316 Medical Center North
    Nashville, TN 37232-2729
Profile

Dr. Beauchamp is the John Clinton Foshee Distinguished Professor of Surgery, Chairman of the Section of Surgical Sciences, and Surgeon-in-Chief of Vanderbilt University Hospital and has held these positions since July 2001 and on the faculty at Vanderbilt since December 1994.
Read more ....

Dr. Beauchamp is the John Clinton Foshee Distinguished Professor of Surgery, Chairman of the Section of Surgical Sciences, and Surgeon-in-Chief of Vanderbilt University Hospital and has held these positions since July 2001 and on the faculty at Vanderbilt since December 1994. His clinical practice encompassed Surgical Oncology including GI cancers, melanoma, sarcomas and breast cancer for almost 20 years, but is currently focused on breast cancer.

Dr. Beauchamp holds joint appointments as Professor in the Departments of Cell and Developmental Biology and Cancer Biology. He also serves as Deputy Director of the Vanderbilt-Ingram Cancer Center and now as co-leader of the GI Cancer Program. Dr. Beauchamp has two active R01 grants from NIH, and co-leads one of the main projects in the GI Cancer SPORE. His primary area of research interest has been in colorectal carcinogenesis, the biology of cancer cell invasion and metastasis, and in the identification of novel molecular biomarkers and therapeutic targets in colorectal and other alimentary tract malignancies. His work applies genomic, transcriptomic and proteomic technology to identify novel biomarkers and therapeutic targets in colorectal cancer. He also uses molecular genetics, chemical biology and cell biological approaches to examine mechanistic questions in cancer biology in both cell culture and mouse models. They have also developed a chemical biology project and have identified probes that inhibit Epithelial-to-Mesenchymal transition and restore E-cadherin expression in cells in which E-cadherin transcription is repressed. In addition to the basic cancer research, Dr. Beauchamp works in collaboration with his Medical Oncology and Radiation Oncology colleagues to accrue cancer patients to approved cancer clinical trials. He has trained and mentored numerous junior faculty members, physician scientist fellows, medical students, graduate students and post-doctoral fellows in his laboratory.

Education
  • B.S., Texas Tech University, Lubbock, Texas, 1978
  • M.D., The University of Texas Medical Branch, Galveston, Texas, 1982
Research Description

R. Daniel Beauchamp, MD, is the John Clinton Foshee Distinguished Professor of Surgery, Chairman of the Section of Surgical Sciences, and Surgeon-in-Chief of Vanderbilt University Hospital and has held these positions since July 2001 and on the faculty at Vanderbilt since December 1994. He holds joint appointments as professor in the departments of Cell and Developmental Biology and Cancer Biology. He also serves as Deputy Director of the Vanderbilt-Ingram Cancer Center. Dr. Beauchamp has two active R01 grants from NIH, and leads one of the main projects in the GI Cancer SPORE. Dr. Beauchamp's primary area of research interest has been in colorectal carcinogenesis, the biology of cancer cell invasion and metastasis, and in the identification of novel molecular biomarkers and therapeutic targets in colorectal and other alimentary tract malignancies. His work applies DNA microarray and proteomic technology to identify novel biomarkers and therapeutic targets in human colorectal cancer samples. He also uses molecular genetics, chemical biology and cell biological approaches to examine mechanistic questions in cancer biology in both cell culture and mouse models. In addition to the basic cancer research Dr. Beauchamp works in collaboration with his Medical Oncology and Radiation Oncology colleagues to accrue cancer patients to approved clinical trials. He has trained and mentored numerous junior faculty members, physician scientist fellows, medical students, graduate students and post-doctoral fellows in his laboratory. He is one of the few surgeon members of the ASCI.

Clinical Interest

Dr. Beauchamp's clinical practice is currently focused in the surgical care of breast cancer patients. He has clinic at the Vanderbilt One Hundred Oaks facility in the Vanderbilt Breast Center and performs surgical procedures at Vanderbilt University Hospital.

Clinical Research Description

Dr. Beauchamp's clinical practice is primarily in Surgical Oncology. He participates in the multidisciplinary Vanderbilt Breast Center clinic. Dr. Beauchamp's practice includes patients with breast cancers and premalignant breast diseases. He participate in care with a multidisciplinary team along with Radiologists, Medical Oncologists, Pathologists, Radiation Oncologists and the Genetic counseling service to provide the most current and comprehensive diagnostic and therapeutic care available.

Publications